Esphera SynBio Inc.
Toronto, CA · 2 known investors
Esphera designs transgenes that enable budding exosomes to carry multimeric proteins for therapeutic applications, with initial focus on modifying tumor-derived exosomes to create immunostimulatory cancer vaccines.
Founders & leadership
BL
Brian LichtyFounder, CEO
CI
Carolina IlkowFounder, CSO
JB
John BellFounder, President